We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+2.52%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$7.16B
AUM Growth
+$666M
(+10%)
Cap. Flow
+$831M
Cap. Flow
% of AUM
11.61%
Top 10 Holdings %
Top 10 Hldgs %
17.05%
Holding
983
New
189
Increased
207
Reduced
145
Closed
240
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$146M |
| 2 |
Gilead Sciences
GILD
|
+$116M |
| 3 |
Amazon
AMZN
|
+$86.4M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$84.7M |
| 5 |
Analog Devices
ADI
|
+$80M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$73.2M |
| 2 |
Palo Alto Networks
PANW
|
+$59.8M |
| 3 |
Alkermes
ALKS
|
+$55.3M |
| 4 |
Accenture
ACN
|
+$53.8M |
| 5 |
Johnson & Johnson
JNJ
|
+$53M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 36.05% |
| 2 | Technology | 29.2% |
| 3 | Financials | 8.76% |
| 4 | Industrials | 7.7% |
| 5 | Communication Services | 4.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Supernus Pharmaceuticals
SUPN
$2.53B
| $26.9M | 0.38% |
793,767
+225,188
| +40% | +$7.33M |
|
77
Tyler Technologies
TYL
$12.8B
| $26.3M | 0.37% |
75,604
+5,436
| +8% | +$2.02M |
|
78
AbbVie
ABBV
$431B
| $25.1M | 0.35% |
+187,088
| New | +$26.8M |
|
79
Teleflex
TFX
$6.24B
| $25M | 0.35% |
124,088
+59,471
| +92% | +$14.2M |
|
|
LHCG
80
DELISTED
LHC Group LLC
LHCG
| $24.9M | 0.35% |
152,303
-28,515
| -16% | -$4.62M |
|
|
81
Johnson & Johnson
JNJ
$612B
| $24.8M | 0.35% |
151,600
-313,066
| -67% | -$53M |
|
82
Simply Good Foods
SMPL
$1.01B
| $24.7M | 0.35% |
773,620
+9,800
| +1% | +$322K |
|
|
CTXS
83
DELISTED
Citrix Systems Inc
CTXS
| $24.5M | 0.34% |
235,296
+39,325
| +20% | +$4.03M |
|
84
nVent Electric
NVT
$26.4B
| $23.9M | 0.33% |
754,990
+228,192
| +43% | +$7.63M |
|
|
STKL
85
DELISTED
SunOpta
STKL
| $23.4M | 0.33% |
2,569,831
+86,749
| +3% | +$823K |
|
86
Verizon
VZ
$194B
| $22.8M | 0.32% |
+599,998
| New | +$26.7M |
|
87
Monolithic Power Systems
MPWR
$66.3B
| $22.7M | 0.32% |
62,431
+6,408
| +11% | +$2.85M |
|
88
Vontier
VNT
$4.78B
| $22.7M | 0.32% |
1,355,947
+688,925
| +103% | +$15.4M |
|
89
Eaton
ETN
$173B
| $22.2M | 0.31% |
166,619
+74,108
| +80% | +$10.4M |
|
90
Becton Dickinson
BDX
$46.9B
| $22.1M | 0.31% |
99,367
+38,429
| +63% | +$9.56M |
|
91
NetApp
NTAP
$37.5B
| $22.1M | 0.31% |
357,903
+203,629
| +132% | +$14.2M |
|
92
First Horizon
FHN
$12.4B
| $21.9M | 0.31% |
955,000
-280,000
| -23% | -$6.36M |
|
93
Ascendis Pharma A/S
ASND
$16B
| $21.8M | 0.31% |
211,393
+105,267
| +99% | +$9.98M |
|
94
CVS Health
CVS
$133B
| $21.4M | 0.3% |
224,414
+122,610
| +120% | +$12.1M |
|
|
MRUS
95
DELISTED
Merus
MRUS
| $21.1M | 0.29% |
1,051,955
+586,752
| +126% | +$14M |
|
96
Baxter International
BAX
$14.6B
| $21M | 0.29% |
390,073
+57
| +0% | +$3.43K |
|
|
AAWW
97
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $20.3M | 0.28% |
+212,712
| New | +$18.8M |
|
|
CYBR
98
DELISTED
CyberArk
CYBR
| $20.2M | 0.28% |
134,398
+12,677
| +10% | +$1.81M |
|
99
Rogers Corp
ROG
$2.37B
| $20.1M | 0.28% |
83,152
-11,843
| -12% | -$3.07M |
|
100
Monster Beverage
MNST
$92.1B
| $20.1M | 0.28% |
461,770
+135,420
| +41% | +$6.24M |
|
Similar funds
PAM
TCIIS
UIM
VAI
Woodline Partners's Q3 2022 Portfolio in Review
As of Q3 2022, Woodline Partners held 983 positions worth $7.16B, up 10% from $6.49B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Woodline Partners deployed $831M of net new capital in Q3 2022, opening 189 new positions and adding to 207 existing holdings. Its largest new stake was Amazon: 683,398 shares worth $77.2M.
By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 35% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Eli Lilly, an estimated $73.2M trimmed.
- Woodline Partners's largest Q3 2022 buy was Amazon: 683,398 shares worth $77.2M.
- Woodline Partners added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2022, an estimated $146M increase.
- Woodline Partners's biggest Q3 2022 reduction was Eli Lilly, cutting an estimated $73.2M.
- Woodline Partners fully exited Palo Alto Networks in Q3 2022, selling an estimated $59.8M.
- Woodline Partners's ten largest holdings make up 17% of its $7.16B portfolio in Q3 2022.
- Woodline Partners opened 189 new positions and closed 240 in Q3 2022.
- Woodline Partners's portfolio value rose 10% quarter-over-quarter to $7.16B.
Based on Woodline Partners's 13F filing for Q3 2022, filed 14 Nov 2022.